ARGX | argenx SE | 轉虧為盈 | 轉虧為盈 |
BAX | Baxter International Inc. | 轉虧為盈 | -94.4% |
BIO | Bio-Rad Laboratories, Inc. | 轉虧為盈 | 514.7% |
BNTX | BioNTech SE | 轉虧為盈 | 23.3% |
ELAN | Elanco Animal Health Incorporated | 轉虧為盈 | 轉虧為盈 |
ILMN | Illumina, Inc. | 轉虧為盈 | 轉虧為盈 |
IMGN | ImmunoGen, Inc. | 轉虧為盈 | 轉虧為盈 |
INCY | Incyte Corporation | 轉虧為盈 | -37.8% |
MRNA | Moderna, Inc. | 轉虧為盈 | 轉虧為盈 |
PEN | Penumbra, Inc. | 轉虧為盈 | 220.5% |
QGEN | Qiagen N.V. | 轉虧為盈 | 26% |
RETA | Reata Pharmaceuticals, Inc. | 轉虧為盈 | 轉虧為盈 |
SGFY | Signify Health, Inc. | 轉虧為盈 | 1754.6% |
VRTX | Vertex Pharmaceuticals Incorporated | 轉虧為盈 | 1% |
VTRS | Viatris Inc. | 轉虧為盈 | -71.4% |
PFE | Pfizer Inc. | 20827.9% | 轉虧為盈 |
RPRX | Royalty Pharma plc | 1006.9% | 654.3% |
EW | Edwards Lifesciences Corporation | 679.9% | 697.8% |
SRPT | Sarepta Therapeutics, Inc. | 507% | 轉虧為盈 |
THC | Tenet Healthcare Corporation | 316.7% | 367.3% |
BRKR | Bruker Corporation | 251.2% | -53.6% |
SNN | Smith & Nephew plc | 235.3% | 20.9% |
AMGN | Amgen Inc. | 211.2% | 63.6% |
GRFS | Grifols, S.A. | 152.2% | -13.9% |
ABMD | Abiomed, Inc. | 145.5% | 86.4% |
SWAV | ShockWave Medical, Inc. | 137% | 41.5% |
ALC | Alcon Inc. | 106.6% | 28.9% |
JAZZ | Jazz Pharmaceuticals plc | 99.8% | 46.5% |
CAH | Cardinal Health, Inc. | 86.7% | 8220% |
INSP | Inspire Medical Systems, Inc. | 76.3% | 轉虧為盈 |
GMED | Globus Medical, Inc. | 74.7% | 5094% |
STVN | Stevanato Group S.p.A. | 64.8% | -20.8% |
TAK | Takeda Pharmaceutical Company Limited | 61.7% | 轉虧為盈 |
LNTH | Lantheus Holdings, Inc. | 61.4% | -0.7% |
SNY | Sanofi | 56.6% | 11.5% |
WST | West Pharmaceutical Services, Inc. | 53.5% | -15.7% |
UNH | UnitedHealth Group Incorporated | 53.1% | 3.7% |
NVS | Novartis AG | 46.7% | 81.1% |
BSX | Boston Scientific Corporation | 46.3% | -7.1% |
SOLV | Solventum Corporation | 45.1% | -57.2% |
BDX | Becton, Dickinson and Company | 41.6% | 289.8% |
BDXA | Becton, Dickinson and Company | 41.6% | 289.8% |
BDXB | Becton, Dickinson and Company | 41.6% | 289.8% |
COO | The Cooper Companies, Inc. | 40% | 39.1% |
NVO | Novo Nordisk A/S | 38.9% | 21.5% |
ALGN | Align Technology, Inc. | 34.1% | -4.5% |
RVTY | Revvity, Inc. | 33.6% | 883.3% |
IDXX | IDEXX Laboratories, Inc. | 32.4% | 9.7% |
ICLR | ICON Public Limited Company | 32% | 20.4% |
HALO | Halozyme Therapeutics, Inc. | 31.9% | 67.4% |
NBIX | Neurocrine Biosciences, Inc. | 30.5% | 56.2% |
ABT | Abbott Laboratories | 29.4% | 14.6% |
MMSI | Merit Medical Systems, Inc. | 28.9% | 10.1% |
ATR | AptarGroup, Inc. | 23.9% | 18.7% |
FMS | Fresenius Medical Care AG & Co. KGaA | 23.6% | 152.5% |
MOH | Molina Healthcare, Inc. | 22.6% | 33.1% |
MEDP | Medpace Holdings, Inc. | 19.9% | 36.8% |
STE | STERIS plc | 15.5% | 30.1% |
WAT | Waters Corporation | 15.5% | 20% |
GEHC | GE HealthCare Technologies Inc. | 14.4% | 25.6% |
UHS | Universal Health Services, Inc. | 13.8% | 54.9% |
ENSG | The Ensign Group, Inc. | 13.7% | 22.8% |
TMO | Thermo Fisher Scientific Inc. | 9.4% | -5% |
DVA | DaVita Inc. | 8.6% | -13% |
MDT | Medtronic plc | 8.6% | 39.7% |
RMD | ResMed Inc. | 8% | 41.9% |
VEEV | Veeva Systems Inc. | 6.6% | 37.5% |
A | Agilent Technologies, Inc. | 0.7% | -26.1% |
HCA | HCA Healthcare, Inc. | -0.1% | 17.7% |
TECH | Bio-Techne Corporation | -2.5% | -34.1% |
HLN | Haleon plc | -5.5% | 1.7% |
DHR | Danaher Corporation | -6.5% | -27.5% |
HOLX | Hologic, Inc. | -6.9% | 97.1% |
ISRG | Intuitive Surgical, Inc. | -8.1% | 35.9% |
DXCM | DexCom, Inc. | -8.7% | 11.5% |
GMAB | Genmab A/S | -9.2% | -40.5% |
CHE | Chemed Corporation | -9.6% | 1.1% |
REGN | Regeneron Pharmaceuticals, Inc. | -11% | 33% |
EHC | Encompass Health Corporation | -11.3% | 26.8% |
MTD | Mettler-Toledo International Inc. | -11.8% | 4.9% |
ZTS | Zoetis Inc. | -12.1% | 14.4% |
SYK | Stryker Corporation | -12.8% | 20.5% |
PKI | PerkinElmer, Inc. | -14.6% | -80.2% |
DGX | Quest Diagnostics Incorporated | -18.3% | 0.4% |
CNC | Centene Corporation | -18.8% | 52% |
UTHR | United Therapeutics Corporation | -19% | 15.5% |
ABC | AmerisourceBergen Corporation | -19.1% | 25.4% |
HSIC | Henry Schein, Inc. | -20% | -27.7% |
BIIB | Biogen Inc. | -22.5% | 轉虧為盈 |
TFX | Teleflex Incorporated | -23% | -19.1% |
DOCS | Doximity, Inc. | -23.9% | 44.3% |
EXEL | Exelixis, Inc. | -26.5% | 11232.7% |
CRL | Charles River Laboratories International, Inc. | -26.9% | -21.4% |
ABBV | AbbVie Inc. | -27% | -12.2% |
LH | Laboratory Corporation of America Holdings | -30.9% | -7.6% |
GILD | Gilead Sciences, Inc. | -34.1% | -42.5% |
RDY | Dr. Reddy's Laboratories Limited | -35.2% | -15.2% |
ANTM | Elevance Health Inc. | -37.4% | -21.2% |
ELV | Elevance Health Inc. | -37.4% | -21.2% |
HUM | Humana Inc. | -38.6% | -42.3% |
AZN | AstraZeneca PLC | -42% | 4% |
CI | Cigna Corporation | -43% | 1702.4% |
BMRN | BioMarin Pharmaceutical Inc. | -43.6% | 162.7% |
MASI | Masimo Corporation | -44.5% | -7.5% |
IQV | IQVIA Holdings Inc. | -44.8% | -5.9% |
JNJ | Johnson & Johnson | -45.3% | -89.6% |
ZBH | Zimmer Biomet Holdings, Inc. | -46.7% | 53.2% |
MRK | Merck & Co., Inc. | -55.1% | -33.5% |
LLY | Eli Lilly and Company | -63% | 轉虧為盈 |
BMY | Bristol-Myers Squibb Company | -63.1% | -37.2% |
PODD | Insulet Corporation | -66.3% | 49.3% |
MCK | McKesson Corporation | -67.5% | -63.7% |
HQY | HealthEquity, Inc. | -78.2% | -61.1% |
PHG | Koninklijke Philips N.V. | -78.8% | 105.7% |
CVS | CVS Health Corporation | -94.6% | -96.2% |
COR | Cencora | -99.3% | -99% |
CTLT | Catalent, Inc. | -100% | - |
GSK | GSK plc | -100% | -100% |
RGEN | Repligen Corporation | -100% | -100% |
WBA | Walgreens Boots Alliance, Inc. | -100% | - |
ALNY | Alnylam Pharmaceuticals, Inc. | - | -100% |
ASND | Ascendis Pharma A/S | - | - |
BGNE | BeiGene, Ltd. | - | -100% |
BLCO | Bausch + Lomb Corporation | - | - |
BPMC | Blueprint Medicines Corporation | - | - |
CERE | Cerevel Therapeutics Holdings, Inc. | - | - |
CYTK | Cytokinetics, Incorporated | - | - |
EXAS | Exact Sciences Corporation | - | -100% |
GKOS | Glaukos Corporation | - | - |
INSM | Insmed Incorporated | - | - |
IONS | Ionis Pharmaceuticals, Inc. | - | - |
ITCI | Intra-Cellular Therapies, Inc. | - | - |
KRTX | Karuna Therapeutics, Inc. | - | - |
LEGN | Legend Biotech Corporation | - | - |
MDGL | Madrigal Pharmaceuticals, Inc. | - | - |
MESO | Mesoblast Limited | - | - |
NTRA | Natera, Inc. | - | - |
NUVL | Nuvalent, Inc. | - | - |
OSH | Oak Street Health, Inc. | - | - |
PCVX | Vaxcyte, Inc. | - | - |
RCM | R1 RCM Inc. | - | -100% |
RVMD | Revolution Medicines, Inc. | - | - |
RXDX | Prometheus Biosciences, Inc. | - | - |
SGEN | Seagen Inc. | - | - |
SMMT | Summit Therapeutics Inc. | - | - |
TEVA | Teva Pharmaceutical Industries Limited | - | -100% |
ROIV | Roivant Sciences Ltd. | - | - |
